APUS · Apimeds Pharmaceuticals US, Inc. · Analyst Estimates
$2.71
-0.03 (-0.92%)
At close · Nov 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date these condensed consolidated financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$4.08M
Shares
1.51M
Volume · Nov 6
16.69K
Avg daily vol (3M)
3.7M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Analyst Estimates
Compare analyst forecasts for Apimeds Pharmaceuticals US, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
This verified capture contains no analyst forecast observations. Older snapshots remain in the history.
Captured 2026-09-18 08:34 UTC · Publication dates shown per estimate · 0 metric / period groups